NASDAQ · CURX
Curanex Pharmaceuticals Inc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CURX: Nov 13, 2026
Curanex Pharmaceuticals Inc Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.8.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews- RTTNews · May 14, 12:11 PM EDTCuranex Ends Q1 With $4 Mln; Plans IND For Phyto-N In Treating Ulcerative Colitis(RTTNews) – Curanex Pharmaceuticals Inc. (CURX), a pharmaceutical development company, on Thursday announced first quarter results and highlighted progress of its lead drug candidate Phyto-N, which is being advanced towards a planned FDA submission for ulcerative colitis.
- RTTNews · Apr 6, 11:16 AM EDTCuranex Showcases Patient Case Study Highlighting Potential Of Phyto-N; Stock Up(RTTNews) – Curanex Pharmaceuticals Inc. (CURX) saw its stock rise by 6% after the company highlighted a compelling patient case study supporting the potential of its lead program, Phyto-N, in cancer cachexia and advanced cancer supportive care.
- RTTNews · Feb 25, 10:01 AM ESTCuranex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis(RTTNews) – Curanex Pharmaceuticals Inc. (CURX), development-stage company focused on botanical drugs for inflammatory diseases, announced the completion of a Good Manufacturing Practice or GMP pilot-scale batch of its lead candidate, Phyto-N. The milestone will support the compa
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Curanex Pharmaceuticals Inc from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.